Trident Texofab (540726.BO) Stock Price
Trident Texofab Price
Revenue has compounded at 10.8% per year over the past 12 years to 1.18 B INR. Earnings per share have grown at 3.8% per year over the last 12 years. Trident Texofab's net margin stands at 0.6%, broadly stable from 1.2% several years earlier. Trident Texofab currently offers a dividend yield of about 2.44%. The payout ratio is around 47% of earnings.
Trident Texofab stock price
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Trident Texofab business model & stock analysis
Frequently asked questions about Trident Texofab
Converted at the current exchange rate, the Trident Texofab share trades at 0.16 EUR (17.06 INR).
The revenue cannot currently be calculated for Trident Texofab.
The profit cannot currently be calculated for Trident Texofab.
The P/E ratio cannot be calculated for Trident Texofab at the moment.
The P/S cannot be calculated for Trident Texofab currently.
The Eulerpool Quality Score for Trident Texofab is 6/10.
The ISIN of Trident Texofab is INE071Y01013. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of Trident Texofab is 540726.BO. The ticker symbol is used to trade Trident Texofab shares on the stock exchange.
Trident Texofab stock
Trident Texofab Peer Group
Trident Texofab FIGI
All fundamentals and in-depth analysis of Trident Texofab
Our stock analysis for Trident Texofab stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Trident Texofab. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.